Neuroptimal

24 views
Skip to first unread message

Dr LOREN PEDERSEN

unread,
Dec 12, 2020, 10:05:50 AM12/12/20
to aapbm...@lists.aapb.org, isnr_memb...@googlegroups.com
Hi All,
 
Does anyone have any information and/or experience with the Neuroptimal neurofeedback device? I had a patient mention it recently and the Neuroptimal claims to do neurotherapy in different way (Dynamical) from traditional neurofeedback. It supposedly doesn't need an EEG test, a qEEG, or even a diagnosis.
 
I appreciate your time. Thank you! 
 
Best,
Loren Pedersen

Note: This message, including attachments, may contain privileged and / or confidential information. Any distribution or use of this communication by someone else may be illegal. If you are not the intended recipient, please notify the sender by answering this message and delete it from your system. Thank you.

Remarque: Ce message, y compris les pièces jointes, peut contenir des informations privilégiées et / ou confidentielles. Toute distribution ou utilisation de cette communication par quelqu'un d'autre peut être illégale. Si vous n'êtes pas le destinataire prévu, s'il vous plaît avisez l'expéditeur en répondant à ce message et supprimez-le de votre système. Je vous remercie.

Nota: Este mensaje, incluidos los archivos adjuntos, puede contener información privilegiada y / o confidencial. Cualquier distribución o uso de esta comunicación por parte de otra persona puede ser ilegal. Si no es el destinatario previsto, notifique al remitente respondiendo este mensaje y elimínelo de su sistema. Gracias.

 

D Corydon Hammond

unread,
Dec 12, 2020, 11:50:32 AM12/12/20
to isnr_memb...@googlegroups.com

I have had 14 different neurofeedback systems through the years, and NeuroOptimal was one of them.  I consider it a one-size-fits-all system in that the electrodes are only placed at C3 and C4 and it does the same thing.  I found it could produce results but more slowly than other systems, and with some patients it was too sedating.  My greatest objection to it has been that they are willing to sell it to anyone with the money to buy it, which I consider unethical, rather than only to licensed professionals.  I remember a schizophrenic woman talking with me about neurofeedback.  She lived a couple of hours away and I suggested a practitioner who was closer to her.  Later I learned that she talked with someone at NeuroOptimal and they convinced her that she could treat herself and sold her a system. 

 

D. Corydon Hammond

--
You received this message because you are subscribed to the Google Groups "ISNR_Members_Forum" group.
To unsubscribe from this group and stop receiving emails from it, send an email to isnr_members_fo...@googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/isnr_members_forum/1820382047.108864.1607722965495%40connect.xfinity.com.

Kim Calder Stegemann

unread,
Dec 12, 2020, 2:28:34 PM12/12/20
to isnr_memb...@googlegroups.com

Theoretically speaking, how are systems like NeurOptimal, LENS, or even the Direct NFB system similar or different?  


For proprietary reasons, it is difficult to know the "science" behind each approach, and all focus on the brain "resetting" itself without any volitional or intentional control/learning.  


I look forward to hearing your thoughts.


Regards, Kim


Kim Calder Stegemann, Ph.D., M.Sc., M.A., B.Ed.
Professor Emerita, TRU

From: isnr_memb...@googlegroups.com <isnr_memb...@googlegroups.com> on behalf of D Corydon Hammond <d.c.h...@utah.edu>
Sent: December 12, 2020 8:39:34 AM
To: isnr_memb...@googlegroups.com
Subject: RE: Neuroptimal
 

Dr LOREN PEDERSEN

unread,
Dec 14, 2020, 5:52:05 AM12/14/20
to aapbm...@lists.aapb.org, Siegfried Othmer, isnr_memb...@googlegroups.com
Many thanks to Siegfried Othmer, Claire Ruckert, Joseph Castellano, Taylor Williams Capozziello, D Corydon Hammond, Dan Corley, Steve Baskin, and Kim Calder Stegemann for your responses to my inquiry about Neuroptimal!
(and any others I may have missed).
 
Your comments and suggestions were very informative and helpful.
 
Best,
Loren Pedersen, PhD
On 12/12/2020 3:58 PM Siegfried Othmer <sieg...@eeginfo.com> wrote:
 
 
Steve—
 
There is actually one publication out there that deals overtly with a clinical condition. But Val discouraged the publication of more such papers. After a number of years one can apply other criteria, such as customer satisfaction—both practitioner and client. There is also cross-system comparison. 
 
In one case of a young girl with seizure disorder, the practitioners used both NeurOptimal and our system. Both clearly contributed to recovery, each in its own way, in the observation of the therapists. This kind of report—out of France in this case—gets my attention. 
 
Siegfried Othmer, Ph.D.
Chief Scientist, The EEG Institute
Los Angeles 

Alvarez, J., Meyer, F.L., Granoff, D.L., and Lundy, A. (2013) The effect of EEG biofeedback on reducing postcancer cognitive impairment. Integr Cancer Ther 12(6):475–487. 

On Dec 12, 2020, at 8:09 AM, St...@neinh.com wrote:

Show me the data. Anyone can theorize and hypothesize elegantly about anything. Science needs data that can be replicated. 
Steve Baskin
 
Steven M. Baskin, PhD
New England Institute for Neurology and Headache
Greenwich Hospital of Yale New Haven Health
203-914-1907 (fax)
 


Sent from my iPhone

On Dec 12, 2020, at 7:47 AM, Siegfried Othmer < sieg...@eeginfo.com> wrote:

It is easy to critique NeurOptimal for many reasons. But there is method here, and we can try to understand it even if we don’t approve of one or another aspect of the operation. NeurOptimal operates on what the rest of the field refers to as inhibit-based training. It simply calls the brain’s attention to brief episodes of excursion into dysregulation. This is an exemplar of non-prescriptive training, in which the brain is totally unconstrained with respect to how it responds to the various prompts. Inhibit-training is a feature of most neurofeedback approaches going all the way back to Lubar, and it generally involves no explicit decision-making. It simply works in concert with whatever stimulus- or reinforcement-based training is being done. 
 
It follows that only the prescriptive aspect of the protocol calls for any clinical decision-making. If that is stripped out of the protocol then what is left is readily accessible to any health professional who doesn’t want to make a career out of NF but nevertheless wants to have access to the technology. By the same token, they don’t have to read the tea leaves on a QEEG. 
 
The term “dynamic” refers to the fact that the thresholds on the basis of which fouls are called on the brain are not static but rather track the ongoing brain dynamics. Our own approach has been similar in this respect for thirty years. 
 
As for training while the person may be distracted or even asleep, even this does not present a problem to the method. Cognition is not involved here. Awareness of the process by the trainee is not necessary to the proceedings. Training likely occurs even in Stage 1 sleep, as the brain remains attentive the the cues that are relevant to itself. 
 
The lack of published research is also deliberate. It follows from the fact that NeurOptimal qualifies for the wellness product exemption with the FDA. If the organization were to start making clinical claims the FDA would be on them like a pack of hounds on a fox. Of course clinical conditions rooted in brain dysregulation can be beneficially affected far and wide. Inhibit-based training is a competent aspect of our protocols. 
 
Now it is true that Val Brown keeps his cards close to the vest, and no one else really knows his algorithms. But that is also quite understandable, in that whatever the algorithms may be, they would be trivially replicable if made known. 
 
Siegfried Othmer, Ph.D.
Chief Scientist, The EEG Institute
Los Angeles
 
 
---
You are currently subscribed to aapbm...@lists.aapb.org.
To unsubscribe from this list please go to: http://www.simplelists.com/confirm.php?u=pYxypTNvIb7kib15p0xGbyOTWIr5jIM9

You may also send an email to in...@aapb.org and a staff member will assist you.

The Association for Applied Psychophysiology and Biofeedback (AAPB) developed and sponsors this forum under the oversight of Michelle Cunningham, Executive Director. It is a private forum for the use of AAPB members and may be used only with AAPB's permission in accordance with the terms set forth below. Postings to the list are not confidential. By use of this list, participants agree: 1) The forum will not be used for improper, objectionable or illegal purposes or in a manner that violates AAPB’s list serv guidelines; 2) To indemnify, defend, and hold harmless AAPB and its directors, officers, members, employees and agents against all loss, expense, damage, including attorney fees and related costs, litigation and threatened litigation arising out of or related to the participant's use of the forum. 3) Improper conduct on AAPB’s listserv may result in disciplinary measures including loss of access to the forum and an action to terminate participant's AAPB membership. Information obtained through the list is not to be construed as professional advice, legal or otherwise, from AAPB. Moreover, information obtained through this list does not necessarily represent the views, position or policy of the AAPB. No part of this publication may be reproduced, used for mailing list preparation or promotional mailings, stored in a retrieval system, or transmitted in any form by any means (electronic, mechanical photocopying, recording, or otherwise) without prior written permission of AAPB. ATTN CANADIAN CITIZENS: To opt into AAPB list serv and email communications and ensure compliance with Canadian Ant-Spam Laws, please visit https://www.aapb.org/i4a/pages/index.cfm?pageID=3745
View current subscription options: https://www.aapb.org/i4a/pages/index.cfm?pageID=3928
The Association for Applied Psychophysiology and Biofeedback, One Parkview Plaza, Suite 800, Oakbrook Terrace IL 60181; in...@aapb.org; (800) 477-8892

Dave Siever

unread,
Dec 14, 2020, 12:35:48 PM12/14/20
to isnr_memb...@googlegroups.com

Hi Cory, I fully support your position on NO. I have witnessed the same thing from over 20 years ago with them.

 

 

Dave Siever

- dancing in the dendrites!

 

Mind Alive Inc.

Edmonton, AB, Canada

800-661-6463

 

This is the youngest day of the rest of your life.

Now go do the youngest thing possible! 

Sean Brock

unread,
Dec 14, 2020, 1:55:01 PM12/14/20
to isnr_memb...@googlegroups.com
I'm curious if you all have an understanding of how NO works or what it is even trying to accomplish. Vague words like optimize or reset or balance are unhelpful. It seems like NO is a secretive about what is actually happening, but I would like to know your experiences.

Warm Regards,

Sean Brock, LPC, BCN

Neuro Colorado
720-232-0834
www.neurocolorado.com
se...@neurocolorado.com
1720 South Bellaire Street, Suite 710
Denver, Co 80222


D Corydon Hammond

unread,
Dec 14, 2020, 3:44:44 PM12/14/20
to isnr_memb...@googlegroups.com

My recollection is that it is focused on reducing the variability in the EEG.

 

Cory

Siegfried Othmer

unread,
Dec 15, 2020, 6:59:48 AM12/15/20
to isnr_memb...@googlegroups.com
How NeurOptimal works can be intimated on the basis of its history. Val Brown got started with fairly conventional NF that incorporated both reward-elements and a conventional inhibit design. He was aiming for a relatively ‘bullet-proof’ design, one that was least likely to evoke adverse responses, and in pursuit of that objective, all standard reinforcement-based elements were squeezed out of the protocol over the course of several years. He was left with an inhibit-only design that was broadly well-tolerated. As far as I can judge, Val has been refining that design ever since.   

The design principles include the key observation that the EEG is not well-described by the Gaussian distribution. It becomes power-law-distributed in the tail, and it is tail-behavior we are concerned with here. These are opposite extremes in the description of natural phenomena. No distribution found in nature cuts off faster than a Gaussian, and nothing in nature cuts off more gradually than a power-law distribution. It follows that something well-fitted with a power-law distribution ought not to be modeled with a Gaussian. 

The use of fixed thresholds is consistent with a Gaussian model; dynamic thresholding is consistent with a power-law model. By using the appropriate model for his inhibit design, Val sets himself apart from the rest of the field, i.e. Z-score training and other inhibit schemes.  When he last presented on the topic, Val described a version of dynamic thresholding that hinged only on the immediate context. That was more aggressive than the approaches to dynamic thresholding that we have been using for about 25 years, which take a longer-term perspective. A second point of departure Val has emphasized is his reliance on the Gabor transform rather than the Fourier transform for his analysis. This is essentially a short-term FFT with a Gaussian windowing function. 

By these means, Val has developed a non-prescriptive method, one in which the brain is totally unconstrained with respect to how it responds to the various prompts. The limited decision-space makes the method accessible to therapists who don’t want to specialize in NF but still want to take advantage of its unique capabilities. In our own worldview, our principal targets in NF are 1) cerebral excitability, and 2) arousal dysregulation, in which central arousal is intimately coupled to affect and autonomic dysregulation. Whereas therapists collectively have many ways to moderate arousal dysregulation, the same does not hold for cerebral excitability. Medical remedies aside, the taming of cerebral excitability is most appropriately achieved with NF. And inhibit-based training is the most innocuous, least troublesome means of encroaching on that objective.

Siegfried Othmer, Ph.D.
Chief Scientist, the EEG Institute
Los Angeles
Reply all
Reply to author
Forward
0 new messages